Upcoming Dividend • Jun 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 June 2026. Payment date: 05 August 2026. Trailing yield: 7.3%. Within top quartile of South Korean dividend payers (4.2%). Higher than average of industry peers (1.4%). Annuncio • Feb 24
Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 12, 2026 Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 12, 2026, at 08:00 Tokyo Standard Time. Location: auditorium, 42, yusangongdan 7-gil, gyeongsangnam-do, yangsan South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩231 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 08 April 2026. Payout ratio is a comfortable 49% but the company is not cash flow positive. Trailing yield: 4.2%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). Buy Or Sell Opportunity • Nov 20
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 13% to ₩7,000. The fair value is estimated to be ₩5,737, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has grown by 17%. Reported Earnings • Nov 19
Third quarter 2025 earnings released: EPS: ₩164 (vs ₩340 in 3Q 2024) Third quarter 2025 results: EPS: ₩164 (down from ₩340 in 3Q 2024). Revenue: ₩23.5b (up 7.0% from 3Q 2024). Net income: ₩2.13b (down 52% from 3Q 2024). Profit margin: 9.1% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 19
Second quarter 2025 earnings released: EPS: ₩167 (vs ₩194 in 2Q 2024) Second quarter 2025 results: EPS: ₩167 (down from ₩194 in 2Q 2024). Revenue: ₩24.3b (up 8.6% from 2Q 2024). Net income: ₩2.17b (down 14% from 2Q 2024). Profit margin: 8.9% (down from 11% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jun 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 06 August 2025. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 4.8%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.7%). Valuation Update With 7 Day Price Move • Apr 19
Investor sentiment deteriorates as stock falls 32% After last week's 32% share price decline to ₩5,650, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 35% over the past three years. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩7,400, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 29% over the past three years. Reported Earnings • Mar 11
Full year 2024 earnings released: EPS: ₩773 (vs ₩654 in FY 2023) Full year 2024 results: EPS: ₩773 (up from ₩654 in FY 2023). Revenue: ₩88.2b (up 1.6% from FY 2023). Net income: ₩10.0b (up 18% from FY 2023). Profit margin: 11% (up from 9.8% in FY 2023). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩8,510, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 19% over the past three years. Annuncio • Feb 20
Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 13, 2025 Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 13, 2025, at 08:00 Tokyo Standard Time. Location: auditorium, 42, yusangongdan 7-gil, gyeongsangnam-do, yangsan South Korea New Risk • Jan 31
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Dividend is not well covered by cash flows (121% cash payout ratio). Valuation Update With 7 Day Price Move • Jan 31
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩11,460, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 55% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 08 April 2025. Payout ratio is a comfortable 29% but the company is paying out more than the cash it is generating. Trailing yield: 3.5%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₩9,480, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years. New Risk • Dec 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (121% cash payout ratio). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩133.0b market cap, or US$93.0m). Valuation Update With 7 Day Price Move • Nov 27
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩6,010, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 16% over the past three years. Reported Earnings • Nov 20
Third quarter 2024 earnings released: EPS: ₩340 (vs ₩235 in 3Q 2023) Third quarter 2024 results: EPS: ₩340 (up from ₩235 in 3Q 2023). Revenue: ₩22.0b (down 3.6% from 3Q 2023). Net income: ₩4.43b (up 45% from 3Q 2023). Profit margin: 20% (up from 13% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩85.8b market cap, or US$65.2m). Upcoming Dividend • Jun 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 June 2024. Payment date: 08 August 2024. Payout ratio is a comfortable 35% but the company is paying out more than the cash it is generating. Trailing yield: 4.1%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.6%). Reported Earnings • Mar 09
Full year 2023 earnings released: EPS: ₩654 (vs ₩472 in FY 2022) Full year 2023 results: EPS: ₩654 (up from ₩472 in FY 2022). Revenue: ₩86.9b (up 3.8% from FY 2022). Net income: ₩8.50b (up 39% from FY 2022). Profit margin: 9.8% (up from 7.3% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share at 3.0% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 04 April 2024. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). Reported Earnings • Aug 19
Second quarter 2023 earnings released: EPS: ₩151 (vs ₩85.00 in 2Q 2022) Second quarter 2023 results: EPS: ₩151 (up from ₩85.00 in 2Q 2022). Revenue: ₩22.9b (up 9.1% from 2Q 2022). Net income: ₩1.96b (up 77% from 2Q 2022). Profit margin: 8.6% (up from 5.3% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Upcoming Dividend • Jun 22
Upcoming dividend of ₩50.00 per share at 3.1% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 44% and the cash payout ratio is 94%. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.2%). Higher than average of industry peers (1.5%). Reported Earnings • May 20
First quarter 2023 earnings released: EPS: ₩65.00 (vs ₩82.00 in 1Q 2022) First quarter 2023 results: EPS: ₩65.00 (down from ₩82.00 in 1Q 2022). Revenue: ₩20.3b (down 2.3% from 1Q 2022). Net income: ₩851.0m (down 20% from 1Q 2022). Profit margin: 4.2% (down from 5.1% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩6,700, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 146% over the past three years. Reported Earnings • Mar 10
Full year 2022 earnings released: EPS: ₩472 (vs ₩477 in FY 2021) Full year 2022 results: EPS: ₩472 (down from ₩477 in FY 2021). Revenue: ₩83.7b (up 9.6% from FY 2021). Net income: ₩6.14b (down 1.0% from FY 2021). Profit margin: 7.3% (down from 8.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 05 April 2023. Payout ratio is a comfortable 51% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₩6,290, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 92% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩25.00 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 10 August 2022. Payout ratio is a comfortable 37% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.2%). In line with average of industry peers (2.4%). Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 16% share price gain to ₩8,400, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 161% over the past three years. Valuation Update With 7 Day Price Move • May 10
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩8,160, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 184% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₩9,880, the stock trades at a trailing P/E ratio of 20.7x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 191% over the past three years. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₩10,100, the stock trades at a trailing P/E ratio of 21.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 211% over the past three years. Reported Earnings • Mar 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₩477 (up from ₩395 in FY 2020). Revenue: ₩76.4b (up 19% from FY 2020). Net income: ₩6.20b (up 21% from FY 2020). Profit margin: 8.1% (up from 8.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Dec 22
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 06 April 2022. Payout ratio is a comfortable 56% but the company is not cash flow positive. Trailing yield: 2.5%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩7,430, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 151% over the past three years. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment improved over the past week After last week's 17% share price gain to ₩6,150, the stock trades at a trailing P/E ratio of 16.8x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 120% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩30.00 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 11 August 2021. Trailing yield: 3.0%. Within top quartile of South Korean dividend payers (2.1%). Higher than average of industry peers (1.4%). Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩7,750, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 203% over the past three years. Reported Earnings • Mar 13
Full year 2020 earnings released: EPS ₩395 (vs ₩525 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₩64.3b (up 4.0% from FY 2019). Net income: ₩5.14b (down 25% from FY 2019). Profit margin: 8.0% (down from 11% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improved over the past week After last week's 15% share price gain to ₩4,630, the stock is trading at a trailing P/E ratio of 7.9x, up from the previous P/E ratio of 6.9x. This compares to an average P/E of 17x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 62%. Annuncio • Feb 25
Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 18, 2021 Chin Yang Industry Co., Ltd., Annual General Meeting, Mar 18, 2021, at 08:00 Korea Standard Time. Is New 90 Day High Low • Feb 24
New 90-day low: ₩3,965 The company is down 12% from its price of ₩4,520 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. Is New 90 Day High Low • Jan 29
New 90-day low: ₩4,000 The company is down 1.0% from its price of ₩4,060 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. Is New 90 Day High Low • Dec 24
New 90-day high: ₩4,960 The company is up 16% from its price of ₩4,280 on 25 September 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩150 Per Share Will be paid on the 7th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%). Valuation Update With 7 Day Price Move • Oct 27
Market pulls back on stock over the past week After last week's 16% share price decline to ₩3,885, the stock is trading at a trailing P/E ratio of 7.4x, down from the previous P/E ratio of 8.8x. This compares to an average P/E of 12x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 45%. Is New 90 Day High Low • Oct 12
New 90-day high: ₩4,400 The company is up 11% from its price of ₩3,950 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 30% over the same period.